CD4 and neoplasm: In contrast, deletion of the lipid phosphatase PTEN in Tregs leads to the hyperactivation of selective effector CD4 + T cell responses but also unleashes anti-tumor immune responses [25–27], suggesting that phospholipid signaling may fine-tune Treg function in diverse contexts.